05/05/2021
6:04 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2021
6:00 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2021
7:03 AM | Kala Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/28/2021
7:00 AM | Kala Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/05/2021
3:31 PM | Kala Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2021
4:35 PM | Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
3:10 PM | Kala Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/25/2021
6:01 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2021
3:53 PM | Kala Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A
| |
01/07/2021
6:02 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/05/2021
3:53 PM | Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
3:50 PM | Iwicki Mark T (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
3:48 PM | Kala Pharmaceuticals (Issuer)
Reumuth Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2020
6:01 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2020
7:36 PM | Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2020
7:32 PM | Kala Pharmaceuticals (Issuer)
Trachtenberg Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2020
7:30 PM | Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2020
7:28 PM | Brazzell Romulus K (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2020
7:24 PM | Iwicki Mark T (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2020
7:22 PM | Kala Pharmaceuticals (Issuer)
Reumuth Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2020
6:03 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2020
6:30 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2020
6:05 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2020
8:58 PM | Kala Pharmaceuticals (Issuer)
Trachtenberg Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2020
8:54 PM | Kala Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2020
8:51 PM | Kala Pharmaceuticals (Issuer)
Paull Robert Bradley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2020
8:48 PM | Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2020
8:47 PM | Brazzell Romulus K (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2020
8:36 PM | Kala Pharmaceuticals (Issuer)
KOVEN ANDREW I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2020
8:31 PM | Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2020
8:25 PM | Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2020
3:05 PM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2020
3:06 PM | Kala Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/11/2020
3:58 PM | Kala Pharmaceuticals (Issuer)
Reumuth Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2020
7:10 AM | Kala Pharmaceuticals (Filer)
| Form DEFA14A
| |
05/26/2020
7:05 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2020
11:15 PM | Kala Pharmaceuticals (Filer)
| Form EFFECT
| |
05/07/2020
4:21 PM | Kala Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/07/2020
6:05 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2020
7:54 AM | Kala Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/29/2020
7:50 AM | Kala Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/13/2020
7:38 AM | Brazzell Romulus K (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2020
6:30 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2020
3:43 PM | Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2020
4:46 PM | Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2020
6:59 AM | Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2020
5:47 PM | Kala Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2020
5:45 PM | Kala Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2020
4:19 PM | Kala Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A
| |
03/10/2020
8:26 PM | Kala Pharmaceuticals (Filer)
| Form 424B5
| |
03/10/2020
8:03 PM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/09/2020
5:05 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2020
4:24 PM | Kala Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2020
6:15 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2020
6:30 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2019
3:06 PM | Kala Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2019
6:19 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2019
4:56 PM | Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2019
4:56 PM | Kala Pharmaceuticals (Issuer)
Trachtenberg Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2019
3:05 PM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2019
3:28 PM | Kala Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2019
6:05 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2019
3:03 PM | Kala Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:02 PM | Kala Pharmaceuticals (Issuer)
PERRY GREGORY D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:02 PM | Kala Pharmaceuticals (Issuer)
Paull Robert Bradley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:02 PM | Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:01 PM | Kala Pharmaceuticals (Issuer)
KOVEN ANDREW I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:01 PM | Kala Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2019
9:41 AM | Kala Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2019
3:36 PM | Kala Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2019
6:06 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2019
3:08 PM | Kala Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/12/2019
3:02 PM | Kala Pharmaceuticals (Filer)
| Form DEF 14A
| |
03/12/2019
7:42 AM | Kala Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2019
7:32 AM | Kala Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2019
3:56 PM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2019
9:16 AM | Hadley Harbor Master Investors L.P. (0001641080) (Filed by)
Kala Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/12/2019
8:57 AM | Kala Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
01/07/2019
6:00 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2019
4:05 PM | Iwicki Mark T (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2019
4:04 PM | Brazzell Romulus K (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2019
4:03 PM | Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2019
4:02 PM | Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2018
3:02 PM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2018
4:07 PM | Kala Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2018
3:01 PM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2018
8:00 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2018
3:19 PM | Kala Pharmaceuticals (Subject)
Longitude Capital Partners II, LLC (Filed by)
| Form SC 13D
| |
10/11/2018
3:11 PM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2018
3:46 PM | Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2018
3:34 PM | Kala Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2018
3:33 PM | Kala Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2018
3:31 PM | Kala Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13D/A
| |
10/05/2018
5:01 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2018
4:26 PM | Kala Pharmaceuticals (Filer)
| Form 424B2
| |
10/02/2018
4:26 PM | Kala Pharmaceuticals (Filer)
| Form 424B2
| |
10/02/2018
3:40 PM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2018
3:38 PM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2018
6:30 AM | Kala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2018
11:15 PM | Kala Pharmaceuticals (Filer)
| Form EFFECT
| |
